Biomerieux
Short position disclosed on July 29, 2026.
0.63% of the capital sold short
1 disclosing funds
51 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
March 15, 2016 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Kintbury Capital LLP | 0.63% | new | July 29, 2026 |
On the other side: the funds that hold Biomerieux Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 15, 2016 | Blackrock Institutional Trust Company, National Association | 0.51% | July 7, 2016 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.32% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Biomerieux, source AMF, data as at July 29, 2026, https://www.quivad.com/action/biomerieux?page=2